Vista Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
956
+73
+8% +$74.6K 0.1% 51
2026
Q1
$812K Sell
883
-75
-8% -$76K 0.08% 62
2025
Q4
$1.03M Buy
958
+138
+17% +$132K 0.1% 45
2025
Q3
$626K Buy
820
+115
+16% +$85.6K 0.06% 64
2025
Q2
$550K Buy
705
+88
+14% +$68.4K 0.06% 60
2025
Q1
$510K Sell
617
-959
-61% -$798K 0.06% 57
2024
Q4
$1.22M Sell
1,576
-143
-8% -$118K 0.14% 28
2024
Q3
$1.52M Buy
1,719
+650
+61% +$584K 0.18% 24
2024
Q2
$968K Buy
1,069
+58
+6% +$46.4K 0.12% 27
2024
Q1
$787K Hold
1,011
0.1% 30
2023
Q4
$589K Buy
+1,011
New +$590K 0.08% 40

Other funds holding LLY

Vista Capital Partners's LLY Position: Q2 2026 in Review

Vista Capital Partners increased its Eli Lilly (LLY) stake by 8.3% in Q2 2026, buying an estimated $74.6K and bringing the position to 956 shares worth $1.15M. The position accounts for 0.1% of the portfolio, ranked #51.

Vista Capital Partners first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.52M in Q3 2024. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vista Capital Partners held 956 shares of Eli Lilly worth $1.15M as of Q2 2026.
  • Vista Capital Partners bought 73 Eli Lilly shares in Q2 2026, an estimated $74.6K.
  • Eli Lilly made up 0.1% of Vista Capital Partners's portfolio in Q2 2026, its #51 holding.
  • Vista Capital Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Vista Capital Partners's Eli Lilly position peaked at $1.52M in Q3 2024.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vista Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.